Saravut (John) J. Weroha, M.D., Ph.D.

  1. Oncologist
  2. Internist

Location

  1. Rochester, Minnesota

Languages

English

Saravut J. Weroha, M.D., Ph.D., is a medical oncologist focusing primarily on gynecologic malignancies and phase 1 clinical trials. His specific areas of clinical focus include:

  • Personalized cancer therapy using ovarian cancer patient-derived xenografts (PDXs), also known as Cancer Avatars, to accurately predict response to anti-cancer treatment.
  • Implementing a multidisciplinary approach to cancer care for strategic utilization of anticancer therapies, such as surgery, radiation, ablation, embolization, and chemotherapy.
  • Searching for molecular targeted therapies based on the specific genetic aberrations found within individual tumors by state-of-the-art next-generation sequencing techniques.
  • Selection of clinical trials that fit the patient's tumor type, molecular profile, and goals of care. This requires careful consideration of individual social factors as well as tumor biology.
  • Above all, working closely with patients as a guide to devise a therapeutic plan which is most optimal for the needs of our patients.

Dr. Weroha works to bridge the gap between promising new therapies in the laboratory and ultimately FDA approval of new therapies for patients with cancer.

  1. Gynecologic cancer
  • Gynecologic oncology
  • Animal surrogates of human tumors (avatars)
  1. 2013
    Fellow - Medical Oncology, Clinical Investigator ProgramMayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2010
    Internship/Residency - Internal Medicine, Clinical Investigator ProgramMayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  3. 2007
    MDUniversity of Kansas School of Medicine
  4. 2007
    PhD - Pharmacology, Toxicology and TherapeuticsUniversity of Kansas School of Medicine
  5. 1998
    BS - Cellular Biology, with Honors and DistinctionUniversity of Kansas

Certifications

  1. 2013
    Medical OncologyAmerican Board of Internal Medicine
  2. 2010
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2010
    ChiefClinical Investigator Program, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine and Science
  2. 2005
    Dissertation Defense with HonorsUniversity of Kansas
  3. 2004
    Best Presentation of Graduate, Medical, and Allied Health Schools at KUMCSigma Xi, The Scientific Research Society
  4. 2004
    Best Graduate Student Presentation in the School of MedicineStudent Research Forum, University of Kansas
  5. 2003
    Comprehensive Exam with HonorsDepartment of Pharmacology and Toxicology, University of Kansas
  6. 1998
    Departmental Honors in BiologyUniversity of Kansas
  7. 1998
    Graduation with Distinction (Top 10%)University of Kansas
  8. 1998
    Outstanding Honors Research ThesisUniversity of Kansas

Professional memberships

  1. 2018 - present
    LeadWatson Clinical Trial Matching Committee
  2. 2018 - present
    Executive Committee MemberMayo Clinic Ovarian Cancer SPORE
  3. 2017 - present
    M.D., Ph.D. Program CommitteeMayo Medical School
  4. 2017 - present
    Grant ReviewerMayo Clinic Ovarian Cancer SPORE
  5. 2017 - present
    Grant ReviewerFraternal Order of Eagles
  6. 2016 - present
    Medical Advisory Board - MemberMinnesota Ovarian Cancer Alliance
  7. 2015 - present
    MemberScientific Review Committee - B, Division of Medical Oncology, Department of Oncology
  8. 2014 - 2017
    Clinical Trials AuditorMayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  9. 2013 - present
    MemberPhase I Protocols Group, Division of Medical Oncology, Department of Oncology
  10. 2013 - present
    MemberGYN Disease Oriented Group (DOG), Department of Oncology
  11. 2010 - present
    MemberAmerican Society of Clinical Oncology
  12. 2001 - present
    MemberAmerican Association for Cancer Research (AACR)
see more

Publications